Urinary tract cancer | Lung cancer | Gastro-oesophageal cancer | Colorectal cancer | |
---|---|---|---|---|
Eligible,a n | 906 | 283 | 437 | 498 |
Excluded,b n (%) | 64 (7) | 68 (24) | 88 (20) | 47 (9) |
Included, n (%) | 842 (93) | 215 (76) | 349 (80) | 451 (91) |
Median time from symptom to diagnosis, days (IQR) | ||||
All subjects | 59 (28–109) | 35 (18–89) | 25 (12–48) | 49 (20–157) |
Age, years | ||||
≤69 | 56 (26–113) | 35 (15–84) | 27 (15–51) | 52 (21–175) |
>69 | 61 (31–107) | 34 (18–91) | 22 (10–42) | 49 (18–125) |
P-value | 0.357 | 0.890 | 0.065 | 0.247 |
Sex | ||||
Male | 58 (29–117) | 32 (19–102) | 24 (10–44) | 49 (19–129) |
Female | 59 (28–106) | 38 (15–87) | 25 (13–50) | 49 (21–165) |
P-value | 0.825 | 0.959 | 0.565 | 0.584 |
↵a These figures include all patients with a relevant alarm symptom and relevant cancer diagnosis.
↵b Cases with incomplete dates for diagnosis of symptom or cancer, first symptom after cancer diagnosis, first symptom or cancer diagnosis after date of death, or no valid date of death were excluded. IQR = interquartile range.